Warby Parker insider files Form 144 for 50,000 shares
Rhea-AI Filing Summary
Form 144 notice for Warby Parker Inc. (WRBY) shows a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney with an aggregate market value of $1,350,500 and an approximate sale date of 09/11/2025. The shares were acquired on 06/28/2017 via previously exercised stock options. The filing reports 105,187,778 shares outstanding. The document also discloses three Rule 10b5-1 sales attributed to David Gilboa in the past three months: 74,500 shares on 07/21/2025 for $1,808,047.95, 500 shares on 07/18/2025 for $12,006.00, and 50,000 shares on 07/01/2025 for $1,101,870.00. The filer certifies absence of undisclosed material adverse information.
Positive
- None.
Negative
- None.
Insights
TL;DR: Insiders disclosed structured sales; transactions are routine and documented under Rule 144/10b5-1.
The filing documents a proposed Rule 144 sale of 50,000 WRBY shares and recent 10b5-1 plan sales by David Gilboa totaling 125,000 shares over the past three months. The shares to be sold were acquired via option exercise in 2017, indicating these are vested, non-restricted shares. The use of a broker and the 10b5-1 framework signals planned, pre-arranged disposals rather than opportunistic trades. Relative to the 105.2 million shares outstanding, the disclosed quantities are small in percentage terms, suggesting limited immediate market impact absent other disclosures.
TL;DR: Disclosure aligns with regulatory requirements; representation of no undisclosed material information is standard.
The form includes the required certification that the seller is not aware of any undisclosed material adverse information and notes adoption/usage of 10b5-1 sales plans. The filing provides acquisition details (06/28/2017) and payment information, fulfilling transparency expectations for insider dispositions. There are no statements of new governance actions, litigation, or other corporate events in this notice.